Trial Profile
A Prospective Randomized, Double Blind Study to Evaluate Safety and Effect With Pre Versus Postoperative Start of Thromboprophylaxis With Dalteparin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2012
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Thromboembolism
- Focus Adverse reactions
- 03 Dec 2012 New trial record